Chargement en cours...

Hormone Therapy and Young-Onset Breast Cancer

Estrogen plus progestin hormone therapy (HT) is associated with an increased risk of postmenopausal breast cancer, but few studies have examined the impact of HT use on the risk of breast cancer in younger women. We assessed the association between estrogen plus progestin HT or unopposed estrogen HT...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Epidemiol
Auteurs principaux: O'Brien, Katie M., Fei, Chunyuan, Sandler, Dale P., Nichols, Hazel B., DeRoo, Lisa A., Weinberg, Clarice R.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2015
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4423525/
https://ncbi.nlm.nih.gov/pubmed/25698646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwu347
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!